2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions

View by Date

Monday, September 23, 2019

1:45pm-3:15pm: Distinct phenotypic expression in a large PKAN cohort in the Dominican Republic

S. Baser, C. Muniz, F. Middleton, R. Ericson, M. Santana Jimenez, C. Bass (Pittsburgh, PA, USA)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3

1:45pm-3:15pm: Distribution Characteristics of Limbs Discomfort in Restless Legs Syndrome

X. Li, YC. Wu, XY. Zhu (Shanghai, China)

Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: Does cognitive-motor training improve the balance in Parkinson’s disease? Randomized clinical trial

M. Terra, N. Barboza, I. de Almeida, M. Bueno, S. Smaili (Londrina, Brazil)

Physical and Occupational Therapy · Les Muses Terrace, Level 3

1:45pm-3:15pm: Does Gait in Real Life differ between People with Parkinson’s Disease and Healthy Controls?

V. Shah, J. Mcnames, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, F. Horak (Portland, OR, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Does information from the Personal KinetiGraph™ (PKG) influence neurologists´ treatment decisions?

M. Sundgren, P. Rousu, A. Johansson (Stockholm, Sweden)

Other · Agora 2 West, Level 2

1:45pm-3:15pm: Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease?

M. Figorilli, A. Marques, M. Meloni, B. Pereira, M. Puligheddu, F. Durif, ML. Fantini (Clermont-Ferrand, France)

Restless Leg Syndrome, RBD and Other Sleep Disorders · Les Muses Terrace, Level 3

1:45pm-3:15pm: Does socio-economic status have impact on quality of life in persons with Parkinson’s disease?

R. Aggarwal, V. Goyal, A. Srivastava, M. Behari (Delhi, India)

Quality of Life · Les Muses Terrace, Level 3

1:45pm-3:15pm: Does Team-based Outpatient Palliative Care Improve Patient or Care Partner-Centered Outcomes in Parkinson’s Disease and Related Disorders?

B. Kluger, M. Katz, N. Galifianakis, K. Hall, S. Pantilat, R. Khan, C. Friedman, W. Cernik, J. Long, J. Kutner, S. Sillau, J. Miyasaki (San Francisco, CA, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Dopamine agonist withdrawal syndrome in Sardinian patients affected by Parkinson’s disease

P. Paolo, R. Pau, G. Orofino, T. Ercoli, F. Marrosu, G. Defazio (Monserrato, Italy)

Psychiatric Manifestations · Les Muses Terrace, Level 3

1:45pm-3:15pm: Dopamine receptor variants alter outcomes with levodopa in early-stage Parkinson’s disease

D. Fischer, P. Auinger, J. Goudreau, A. Cole-Strauss, K. Kieburtz, J. Elm, M. Hacker, P. Charles, J. Lipton, B. Pickut, C. Sortwell (Grand Rapids, MI, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3